Kyntra Bio (KYNB) Long-Term Debt Issuances (2014 - 2015)
Kyntra Bio's (KYNB) quarterly Long-Term Debt Issuances came in at $101000.0 in Q4 2015, little changed year-over-year from $101000.0 in Q4 2014, and little changed quarter-over-quarter from $101000.0 in Q3 2015.
Powered by 
Analysis
Kyntra Bio (KYNB) Long-Term Debt Issuances (2014 - 2015) Analysis & Trends
Kyntra Bio has disclosed Long-Term Debt Issuances across 2 years of filings, most recently posting $101000.0 for Q4 2015.
- In Q4 2015, Long-Term Debt Issuances changed 0.0% year-over-year to $101000.0; the TTM figure through Dec 2019 stood at $101000.0 (down 50.0% YoY), while the FY2023 annual figure was $74.1 million, changed N/A from the prior year.
- Long-Term Debt Issuances came in at $101000.0 for Q4 2015 at Kyntra Bio, roughly flat from $101000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $101000.0 in Q1 2014 to a low of $100000.0 in Q2 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.67 Bn | 192.69 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.06 Bn | 176.88 Bn | 6.22 Bn | 1.32 Bn |
| 3 | Vertex Pharmaceuticals | 131.44 Bn | 123.59 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.87 Bn | 48.73 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.15 Bn | 29.85 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.88 Bn | 30.60 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.16 Bn | 29.16 Bn | 1.16 Mn | - |
| 10 | Kyntra Bio | 32.30 Mn | 32.30 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 101,000.00 |
| Sep 30, 2015 | 101,000.00 |
| Jun 30, 2015 | 100,000.00 |
| Mar 31, 2015 | 101,000.00 |
| Dec 31, 2014 | 101,000.00 |
| Sep 30, 2014 | 101,000.00 |
| Jun 30, 2014 | 100,000.00 |
| Mar 31, 2014 | 101,000.00 |